Connect with us

INDUSTRIAL HEMP

Generex Biotechnology Corporation (OTCMKTS:GNBT) Through Its Subsidiary Receives CE-Mark Certification For Its Express II Syphilis Treponemal Assay

Published

on

Obtaining the CE Marking Certification, which allows commercialization of medical devices requires demands for the completion of rigorous test validation. Thereafter is the submission of an application to the European Union. Of the many companies, which have obtained CE Mark Certification is NuGenerex Diagnostics LLC, a subsidiary of Generex Biotechnology Corporation (OTCMKTS:GNBT).

The integrated healthcare holding company says that it has received the CE Mark for its Express II Syphilis Treponemal Assay. The rapid point-of-care diagnostic assay detects syphilis antibodies in primary and secondary syphilis. Its accuracy is comparable to the standards of laboratory assays and whose specificities are more often than not above 99%. Besides, it is easy to administer in privacy.

CE Marking signifies high standards of safety, health, and environmental protection

There is an alarming rate of increase in the epidemic of syphilis and new infections. The disease has reemerged as a primary sexually transmitted disease with the high-risk groups being at biggest victims. Even the pregnant women have not spared either and particularly those with a concomitant rise of congenital syphilis in newborns. Sadly, projections indicate that infections will rise by 20% by 2022.

The next big cannabis story to hit North America is Phoenix Life Science International (PLSI), traded in the US, but with the largest global production based in the tropics and a license to distribute worldwide. Take a look at Phoenix Life Science International PLSI), Its currently trading under $18 dollars per share on the OTC markets. Learn More Now!

However, there is hope with CE Mark Certification. It implies that any product sold in the EEA is safe and healthy for consumption. The Marking ensures free movement of products. As it is now, NuGenerex Diagnostics is on point in the provision of the necessary efforts. It is not only a fully qualified diagnostic test developer but also a manufacturer under FDA Good Manufacturing Procedures (GMP).

The Chief Medical and Scientific Officer of Generex, Dr. Jason B. Terrell says, “The filing for CE Marking represents a critical advancement in commercialization, and we are now one step closer to delivering this much-needed test to millions of patients across the world.”

Generex has reorganized its portfolio of immuno-oncology assets

For the last two years, the company has been working on the reorganization of its portfolio. This was in line with its vision of being the healthcare holding company that adds significant value to its shareholders. It has settled on strategic businesses partnerships with various institutions such as management services organization (MSO). The aim is to offer optimal care while building ongoing relationships with patients.

Pushing the barriers for global distribution, Phoenix Life Science International (PLSI) is the next cannabis play. Just think Canopy x 100, that is how big their plantation in the tropics will be. No lights, no green houses, just maximum growth + minimal cost = home run. Learn More Now!

   

Learn More About PLSI at your brokerage today!

         

TRENDING STORIES

INDUSTRIAL HEMP4 months ago

Auxly Cannabis Group Inc (OTCMKTS:CBWTF) Acquires 46% Stake In Curative Cannabis And Agrees to Fund Cannabis Cultivation Facility To Produce Ultra Premium Cannabis

Auxly Cannabis Group Inc (OTCMKTS:CBWTF) has entered a deal to take over a 46% stake in Curative Cannabis. The company...

INDUSTRIAL HEMP4 months ago

Canntrust Holdings Inc. (OTCMKTS:CNTTF) Receive Permission From The Town Of Pelham For Their Third Phase Construction

CannTrust Holdings Inc. (OTCMKTS:CNTTF) has announced that they have obtained the required permit to go on with the third phase...

INDUSTRIAL HEMP4 months ago

Indiva Ltd (OTCMKTS:NDVAF) Announces 9.9% Equity Investment In Retailgo Inc.

Indiva Ltd (OTCMKTS:NDVAF) has announced that they are delighted to have finalized an Equity investment of 9.9% in RetailGo Inc....

INDUSTRIAL HEMP4 months ago

Future Farm Technologies Inc (OTCMKTS:FFRMF) Plans To Begin Selling Of Cheery Wine Strain Hemp Seeds And Test Operation Of The Oil Extraction Equipment

Future Farm Technologies Inc (OTCMKTS:FFRMF) is planning to commence the selling of the elite cherry Wine hemp seeds by putting...

INDUSTRIAL HEMP4 months ago

OrganiGram Holdings Inc (OTCMKTS:OGRMF) Sources Hemp With High Levels of CBD From 1812 Hemp

OrganiGram Holdings Inc (OTCMKTS:OGRMF) has entered into a supply pact with 1812 Hemp, an industrial hemp research company based in...

INDUSTRIAL HEMP4 months ago

Kona Gold Solutions Inc (OTCMKTS:KGKG) Declares That They Have Acquired Gold Leaf Distribution

Kona Gold Solutions Inc (OTCMKTS:KGKG) has announced the acquisition of Gold Leaf distribution a newly established distribution company. The Florida...

INDUSTRIAL HEMP4 months ago

CFN Media Group features Supreme Cannabis Company (OTCMKTS:SPRWF) as consideration for investors as their 2019 stock scales up

CFNB Media Group has announced a publication on Supreme Cannabis Company (OTCMKTS:SPRWF) as a licensed producer obsessed with quality. Supreme...

INDUSTRIAL HEMP4 months ago

Village Farms International Inc (OTCMKTS:VFFIF) Leading Greenhouse Crop Protection And Announces Plans To List Its Common Shares On The NASDAQ Market

Village Farms International Inc (OTCMKTS:VFFIF) has announced that they have facilitated Health Canada Pest Management Agency to get approval for...

INDUSTRIAL HEMP4 months ago

Sunniva Inc. (OTCMKTS:SNNVF) Secures More Funding For Growth Strategy As Plans Solidify Towards A Tremendous Year

Sunniva Inc. (OTCMKTS:SNNVF) is solidifying its growth strategy in anticipation for exponential growth this year. Notably, the firm acquired a...

INDUSTRIAL HEMP4 months ago

Curis, Inc. (NASDAQ:CRIS) Announce The Dosing Of The First Mesothelioma Patient In The First Phase Of The CA-170 Study

Curis, Inc. (NASDAQ:CRIS) has announced the enrolment and dosing of the first mesothelioma patient in the first phase of the...

Advertisement

Create a future where the human body can repair, restore, and rejuvenate itself

 

Trading Symbol

OTC: PLSI

The Next Big Global Cannabis Play